GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

The Federal Ministry of Health and Social Welfare, through the National AIDS, Viral Hepatitis and STIs Control Programme ...

The Illinois Department of Public Health has issued a standing order that will allow residents to obtain the HIV preventive ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

The Uganda AIDS Commission (UAC) has reported a continued decline in new HIV infections, though the country still falls short ...

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

Among programs slated for elimination are ones disproportionately impacting LBGTQ people, including HIV prevention and ...